COVID-19 Outbreak - New York City, February 29-June 1, 2020
- PMID: 33211680
- PMCID: PMC7676643
- DOI: 10.15585/mmwr.mm6946a2
COVID-19 Outbreak - New York City, February 29-June 1, 2020
Erratum in
-
Erratum: Vol. 69, No. 46.MMWR Morb Mortal Wkly Rep. 2020 Dec 18;69(50):1930. doi: 10.15585/mmwr.mm6950a7. MMWR Morb Mortal Wkly Rep. 2020. PMID: 33332293 Free PMC article. No abstract available.
Abstract
New York City (NYC) was an epicenter of the coronavirus disease 2019 (COVID-19) outbreak in the United States during spring 2020 (1). During March-May 2020, approximately 203,000 laboratory-confirmed COVID-19 cases were reported to the NYC Department of Health and Mental Hygiene (DOHMH). To obtain more complete data, DOHMH used supplementary information sources and relied on direct data importation and matching of patient identifiers for data on hospitalization status, the occurrence of death, race/ethnicity, and presence of underlying medical conditions. The highest rates of cases, hospitalizations, and deaths were concentrated in communities of color, high-poverty areas, and among persons aged ≥75 years or with underlying conditions. The crude fatality rate was 9.2% overall and 32.1% among hospitalized patients. Using these data to prevent additional infections among NYC residents during subsequent waves of the pandemic, particularly among those at highest risk for hospitalization and death, is critical. Mitigating COVID-19 transmission among vulnerable groups at high risk for hospitalization and death is an urgent priority. Similar to NYC, other jurisdictions might find the use of supplementary information sources valuable in their efforts to prevent COVID-19 infections.
Conflict of interest statement
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.
Figures


Similar articles
-
Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak - New York City, March 11-May 2, 2020.MMWR Morb Mortal Wkly Rep. 2020 May 15;69(19):603-605. doi: 10.15585/mmwr.mm6919e5. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32407306
-
Detection and Genetic Characterization of Community-Based SARS-CoV-2 Infections - New York City, March 2020.MMWR Morb Mortal Wkly Rep. 2020 Jul 17;69(28):918-922. doi: 10.15585/mmwr.mm6928a5. MMWR Morb Mortal Wkly Rep. 2020. PMID: 32678072 Free PMC article.
-
Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):564-565. doi: 10.1093/jpids/piaa103. J Pediatric Infect Dis Soc. 2020. PMID: 32856705 Free PMC article.
-
COVID-19, Australia: Epidemiology Report 18 (Fortnightly reporting period ending 7 June 2020).Commun Dis Intell (2018). 2020 Jun 17;44. doi: 10.33321/cdi.2020.44.52. Commun Dis Intell (2018). 2020. PMID: 32552623
-
Where have all the children gone? Reflections on a flowerless "COVID" spring.J Pediatr Rehabil Med. 2020;13(1):i-iv. doi: 10.3233/PRM-200019. J Pediatr Rehabil Med. 2020. PMID: 32333562 Review. No abstract available.
Cited by
-
Ecuador and Covid-19: A pandemic we won't be able to run away from.Int J Infect Dis. 2021 Aug;109:33-35. doi: 10.1016/j.ijid.2021.05.077. Epub 2021 Jun 2. Int J Infect Dis. 2021. PMID: 34089884 Free PMC article. No abstract available.
-
Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.MMWR Morb Mortal Wkly Rep. 2021 May 14;70(19):712-716. doi: 10.15585/mmwr.mm7019e1. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33983915 Free PMC article.
-
COVID-19 and Neurologic Manifestations: An Experience at Major New York City Hospitals.Cureus. 2022 Apr 11;14(4):e24049. doi: 10.7759/cureus.24049. eCollection 2022 Apr. Cureus. 2022. PMID: 35547415 Free PMC article.
-
COVID-19 pandemic and elective spinal surgery cancelations - what happens to the patients?Spine J. 2021 Dec;21(12):2003-2009. doi: 10.1016/j.spinee.2021.07.019. Epub 2021 Jul 30. Spine J. 2021. PMID: 34339887 Free PMC article.
-
Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics.Sci Rep. 2021 Jul 27;11(1):15295. doi: 10.1038/s41598-021-94654-y. Sci Rep. 2021. PMID: 34315945 Free PMC article.
References
-
- Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2020 statistical notes, no. 20. Hyattsville, MD: US Department of Health and Human Services, CDC, National Center for Health Statistics; 2001.
MeSH terms
LinkOut - more resources
Full Text Sources